Incremental changes in QRS duration predict mortality in patients with atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 11, 2009, Pages 1388-1394

  Lin, Yueh Juh ^a   Liu, Yen Bin ^b   Chu, Ching Chi ^a  

^a EN CHU KONG HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Mortality; QRS duration

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; SPIRONOLACTONE; TICLOPIDINE; WARFARIN;

ADULT; AGED; AGING; ANTICOAGULANT THERAPY; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART RATE; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QRS COMPLEX; REPRODUCIBILITY; RETROSPECTIVE STUDY; STROKE; SURVIVAL RATE; THROMBOEMBOLISM; VALIDATION STUDY;

AGED; ATRIAL FIBRILLATION; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; MALE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TAIWAN;

EID: 70350223827     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02508.x     Document Type: Article

References (29)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 1991 22 : 983 988.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998 98 : 946 952.
3. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 2004 110 : 1042 1046. (Pubitemid 39319000)
4. Silvet H, Amin J, Padmanabhan S, Pai RG. Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction. Am J Cardiol 2001 88 : 182 185.
5. Bode-Schnurbus L, Bocker D, Block M, Gradaus R, Heinecke A, Breithardt G, Borggrefe M. QRS duration: A simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart 2003 89 : 1157 1162.
6. Danciu SC, Gonzalez J, Gandhi N, Sadhu S, Herrera CJ, Kehoe R. Comparison of six-month outcomes and hospitalization rates in heart failure patients with and without preserved left ventricular ejection fraction and with and without intraventricular conduction defect. Am J Cardiol 2006 97 : 256 259.
7. Elhendy A, Hammill SC, Mahoney DW, Pellikka PA. Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 2005 96 : 1082 1088.
8. Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart 2002 88 : 47 51.
9. Grigioni F, Carinci V, Boriani G, Bracchetti G, Potena L, Magnani G, Bacchi-Reggiani L, et al. Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. J Heart Lung Transplant 2002 21 : 899 902.
10. Kreger BE, Anderson KM, Levy D. QRS interval fails to predict coronary disease incidence. The Framingham Study. Arch Intern Med 1991 151 : 1365 1368.
11. Sweeney MO, Hellkamp AS, Lee KL, Lamas GA, mode selection trial (MOST) investigators. Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2005 111 : 2418 2423.
12. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, et al. Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. JAMA 2003 289 : 730 740.
13. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1539 1549. (Pubitemid 40517094)
14. Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP, van Hemel NM. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol. 2007 99 : 1252 1257.
15. Khadjooi K, Foley P, Anthony J, Chalil S, Smith R, Frenneaux M, Leyva F. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart. 2008 94 : 879 883.
16. Taneja T, Mahnert BW, Passman R, Goldberger J, Kadish A. Effects of sex and age on electrocardiographic and cardiac electrophysiological properties in adults. Pacing Clin Electrophysiol 2001 24 : 16 21.
17. Hofmann M, Bauer R, Handrock R, Weidinger G, Goedel-Meinen L. Prognostic value of the QRS duration in patients with heart failure: A subgroup analysis from 24 centers of Val-HeFT. J Card Fail 2005 11 : 523 528.
18. Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol 2004 93 : 244 246.
19. Okin PM, Roman MJ, Devereux RB, Pickering TG, Borer JS, Kligfield P. Time-voltage QRS area of the 12-lead electrocardiogram: Detection of left ventricular hypertrophy. Hypertension 1998 31 : 937 942.
20. Fauchier L, Marie O, Casset-Senon D, Babuty D, Cosnay P, Fauchier JP. Reliability of QRS duration and morphology on surface electrocardiogram to identify ventricular dyssynchrony in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2003 92 : 341 344.
21. Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003 89 : 54 60.
22. Yamada T, Fukunami M, Ohmori M, Iwakura K, Kumagai K, Kondoh N, Tsujimura E, et al. New approach to the estimation of the extent of myocardial fibrosis in patients with dilated cardiomyopathy: Use of signal-averaged electrocardiography. Am Heart J 1993 126 : 626 631.
23. O'Sullivan CA, Henein MY, Sutton R, Coats AJ, Sutton GC, Gibson DG. Abnormal ventricular activation and repolarization during dobutamine stress echocardiography in coronary artery disease. Heart 1998 79 : 468 473.
24. Kruger S, Filzmaier K, Graf J, Kunz D, Stickel T, Hoffmann R, Hanrath P, et al. QRS prolongation on surface ECG and brain natriuretic peptide as indicators of left ventricular systolic dysfunction. J Intern Med 2004 255 : 206 212.
25. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004 109 : 1509 1513
26. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, Levey AS, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Inter 2003 63 : 1121 1129. (Pubitemid 36315592)
27. Mensink GB, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 1997 18 : 1404 1410.
28. Natale A, Zimerman L, Tomassoni G, Kearney M, Kent V, Brandon MJ, Newby K. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 1999 78 : 1431 1433.
29. Van Gelder IC, Wyse DG, Chandler ML, Cooper HA, Olshansky B, Hagens VE, Crijns HJ, et al. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Europace 2006 8 : 935 942.